Skip to main content
Friday, November 13, 2026Nov 13

Two babies infected with dangerous bacteria sometimes found in powdered infant formula

Asian Davis, 33, of Sikeston, Mo., cradles her 8-month-old daughter, Mira White during an interview on Oct. 3, 2023, in St. Louis. Davis and her lawyers say Mira suffered brain damage in March after developing bacterial meningitis tied to powdered infant formula contaminated with Cronobacter sakazakii, a germ known to cause severe disease in young babies. (AP Photo/Michael Thomas)
Asian Davis, 33, of Sikeston, Mo., cradles her 8-month-old daughter, Mira White during an interview on Oct. 3, 2023, in St. Louis. Davis and her lawyers say Mira suffered brain damage in March after developing bacterial meningitis tied to powdered infant formula contaminated with Cronobacter sakazakii, a germ known to cause severe disease in young babies. (AP Photo/Michael Thomas) Asian Davis, 33, of Sikeston, Mo., cradles her 8-month-old daughter, Mira White during an interview on Oct. 3, 2023, in St. Louis. Davis and her lawyers say Mira suffered brain damage in March after developing bacterial meningitis tied to powdered infant formula contaminated with Cronobacter sakazakii, a germ known to cause severe disease in young babies. (AP Photo/Michael Thomas)


ST. LOUIS (AP) — The dangerous bacteria that sparked powdered formula recalls and shortages last year has infected two babies this year, killing a Kentucky child and causing brain damage in a Missouri infant.

Federal health officials confirmed Thursday that two cases of invasive infections caused by cronobacter sakazakii have been reported in 2023, both in infants who consumed powdered infant formula made by Abbott Nutrition, the company at the center of the 2022 crisis.

Food and Drug Administration officials said there was no evidence that the infections were linked to manufacturing and no reason to issue new recalls. The bacteria are found naturally in the environment and also can make their way into infant formula after the packaging is opened.

“There is no indication of a broader public health concern related to this product at this time,” the FDA said in a statement.